The Europe Biomaterials Market was worth $27693 Million in 2018 and estimated to be growing at a CAGR of 14.30%, to reach $54020 Million by 2023. The recent upsurge in the use of biomaterials is mainly attributed to the tremendous research on advancements in medical technology for the efficient functionality of medical implants. Concerns of biocompatibility and demand for superior implant mechanical performance have added to the need for advancements in medical technology.
Increase in government grants and funding, and massive usage of polymer in biomaterials are some of the factors driving the growth of Europe biomaterials market. Further, with the escalation in number of geriatric patients, the demand for usage of biomaterials in cardiology, wound healing, neurology and plastic surgery is also on a rise. Besides, new technologies such as hydrogen scaffolding and decellularized dermal matrixes for grafting will also contribute to the strong market growth.
However, adverse reaction to biomaterial implants, inflammation and fracture issues, high cost associated with and difficulties in manufacturing are the major factors off-putting the growth for Europe biomaterials market.
Based on the types of material, the Europe biomaterials market is categorized into ceramic, metallic, polymers, and natural biomaterials. Polymers will have the fastest growth rate in the coming years owing to its increased applications in healthcare and distinct material properties such as bio- inertness, flexibility, longevity, biocompatibility and durability.
Further, based on application, the market is segmented into orthopaedic, dental, cardiovascular, plastic surgery, tissue engineering, wound healing, ophthalmology, neurological /central nervous systems, and other applications which include drug delivery systems, bariatric surgery, gastrointestinal and urinary applications. With the rising incidences of ophthalmic disorders, the mainstream usage of polymers for ophthalmological purposes will surge in the next few years. Moreover, on the basis of geography, the Europe Market is analysed under various regions namely, UK, Spain, Italy, Germany and France.
Some of the key players in the Europe biomaterials market include Royal DSM, Zimmer Biomet Holdings, Inc., Evonik Industries AG, Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Bayer AG, Carpenter Technology Corporation, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV, and Collagen Matrix, Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Material type
5.1.1 Ceramic
5.1.2 Metallic
5.1.3 Polymer
5.1.4 Natural
5.2 By Application
5.2.1 Orthopaedic
5.2.2 Dental
5.2.3 Cardiovascular
5.2.4 Plastic surgery
5.2.5 Wound healing
5.2.6 Ophthalmology
5.2.7 Tissue engineering
5.2.8 Neurological
5.2.9 Others
6. Geographical Analysis
6.1 Introduction
6.2 U. K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Collagen Matrix, Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Zimmer Biomet Holdings, Inc
8.3 Evonik Industries AG
8.4 Wright Medical Technology, Inc.,
8.5 Corbion N.V
8.6 Berkeley Advanced Biomaterials
8.7 Bayer AG
8.8 Carpenter Technology Corporation
8.9 Covalon Technologies Ltd.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
